Nextbio Capital Management Lp Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Nextbio Capital Management Lp disclosed 17 stock positions valued at approximately $217.40M as of quarter-end June 30, 2026. The largest holdings include PROTAGONIST THERAPEUTICS INC, SHATTUCK LABS INC, and COMPASS PATHWAYS PLC.

Report Period
June 30, 2026
No. of Stocks
17
Portfolio Value
$217.40M
Holdings by Sector
Nextbio Capital Management Lp Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
PROTAGONIST THERAPEUTICS INCPTGXHealthcare12.37%219,333-10,286-4.48%$26,885,839
SHATTUCK LABS INCSTTKHealthcare11.90%3,727,348+577,441+18.33%$25,867,795
COMPASS PATHWAYS PLCCMPSHealthcare11.56%1,775,759-245,648-12.15%$25,126,990
STRUCTURE THERAPEUTICS INCGPCRHealthcare7.71%312,496+179,257+134.54%$16,771,660
RHYTHM PHARMACEUTICALS INCRYTMHealthcare6.73%131,758+5,680+4.51%$14,629,091
PALVELLA THERAPEUTICS INC NEPVLAOther6.32%89,909+7,223+8.74%$13,739,893
XENON PHARMACEUTICALS INCXENEHealthcare5.09%183,225--$11,059,461
ZENAS BIOPHARMA INCZBIOOther4.98%426,736--$10,830,560
ORIC PHARMACEUTICALS INCORICHealthcare3.52%706,124+182,505+34.85%$7,647,323
VAXCYTE INCPCVXHealthcare2.87%107,223+12,000+12.60%$6,232,873
COGENT BIOSCIENCES INCCOGTHealthcare2.33%131,075-113-0.09%$5,072,603
VERASTEM INCVSTMHealthcare2.30%1,306,800--$4,991,976
DISC MEDICINE INCIRONHealthcare1.77%52,655--$3,851,187
PHARVARIS N VPHVSOther1.72%108,055+108,055+100.00%$3,736,542
ZAI LAB LTDZLABHealthcare1.60%183,362--$3,483,878
LB PHARMACEUTICALS INCLBRXOther1.02%68,249+68,249+100.00%$2,215,021
EVOMMUNE INCEVMNOther0.73%119,063-65,000-35.31%$1,582,347
Showing 17 of 17 holdings in the latest reporting period.